30.93
-0.57 (-1.81%)
-0.57 (-1.81%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 841,884 |
|
|||||
| News | - | ||||||
| Day High | 31.56 | Low High |
|||||
| Day Low | 30.345 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc | ARWR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.57 | -1.81% | 30.93 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 31.10 | 30.345 | 31.56 | 30.93 | 31.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,615 | 841,884 | $ 31.02 | $ 26,117,517 | - | 26.81 - 84.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:45:26 | 3 | $ 30.93 | USD |
Period:
Draw Mode:
Arrowhead Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.27B | 105.85M | 90.67M | $ 138.29M | $ -85.38M | -1.36 | -22.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -551.20k | 6.80% |
Arrowhead Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARWR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 35.10 | 35.10 | 30.345 | 33.71 | 958,568 | -4.17 | -11.88% |
| 1 Month | 42.62 | 42.6799 | 30.345 | 36.82 | 798,661 | -11.69 | -27.43% |
| 3 Months | 35.40 | 48.48 | 30.345 | 40.97 | 757,064 | -4.47 | -12.63% |
| 6 Months | 47.37 | 51.11 | 26.81 | 38.73 | 810,909 | -16.44 | -34.71% |
| 1 Year | 62.69 | 84.83 | 26.81 | 48.01 | 735,674 | -31.76 | -50.66% |
| 3 Years | 29.10 | 93.66 | 19.5101 | 51.69 | 1,088,293 | 1.83 | 6.29% |
| 5 Years | 3.60 | 93.66 | 3.01 | 32.98 | 1,340,337 | 27.33 | 759.17% |
Arrowhead Pharmaceuticals Description
| Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease. |